Haplotype analysis of CTLA4 gene and risk of esophageal squamous cell carcinoma in Anyang Area of China

Hepato-Gastroenterology

Volumn 58, Issue 106, 2011, Pages 432-437

  Cheng, Xiao Li ^a   Ning, Tao ^b   Xu, Chang Qing ^a   Li, Yong ^b   Zhu, Bao Song ^c   Hou, Fu Tao ^d   Zhang, Shi Yun ^e   Chen, Zi Ping ^a  

^a SHANDONG UNIVERSITY   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c SOOCHOW UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cytotoxic T lymphocyte antigen 4; Esophageal squamous cell carcinoma; Etiology; Haplotype

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENOMIC DNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CHINA; COMPUTER PROGRAM; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 79958137965     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Parkin DM, et al: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108.
2. McCabe ML, Dlamini Z: Review-The molecular mechanisms of esophageal cancer. Int Immunopharmaco 2005; 15(7-8):1113-1130.
3. Roberts-Thomson IC, Butler WJ: Polymorphism and squamous cell cancer of the esophagus. J Gastroenterol Hepatol 2005; 20(3):486-487. (Pubitemid 40469356)
4. Harper K, et al: CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure and chromosomal location. J Immunol 1991; 147(3):1037-1044.
5. Beck KE, et al: Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol 2006; 24(15):2283-2289. (Pubitemid 46630658)
6. Owerbach D, et al: Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on chromosome 2q31-35. Diabetes 1997; 46(6):1069-1074. (Pubitemid 27221010)
7. Howson JM, et al: A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 2007; 50(4):741-746. (Pubitemid 46355837)
8. Cozar JM, et al: High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum Immunol 2007; 68(8):698-704. (Pubitemid 47126657)
9. Sun T, et al: Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res 2009; 69(15):6011-6014.
10. Pettersson FH, et al: Marker selection for genetic case-control association studies. Nat Protoc 2009; 4(5):743-752.
11. Barrett JC, Cardon LR: Evaluating coverage of genome-wide association studies. Nat Genet 2006; 38(6):659-662. (Pubitemid 43927307)
12. Lahiri DK, Nurnberger Jr. JI: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19(19):5444.
13. Marson BP, et al: Endothelial Nitric Oxide Genotypes and Haplotypes Are Not Associated with End-Stage Renal Disease. DNA Cell Biol. [Epub ahead of print]
14. Kouki T, et al: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 2000; 165(11):6606-6611.
15. Huang D, et al: Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol 2000; 105(1):69-77. (Pubitemid 30125431)
16. Piras G, et al: Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma. Br J Haematol 2005; 129(6):784-790.
17. Maurer M, et al: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002; 54(1):1-8. (Pubitemid 34492947)
18. Erfani N, Razmkhah M, Ghaderi A: Circulating Soluble CTLA4 (sCTLA4) Is Elevated in Patients With Breast Cancer. Cancer Invest 2010; 28(8):828-832.
19. Erfani N, et al: Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet 2006; 165(2):114-120. (Pubitemid 43343504)
20. Humar B, et al: Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002; 21(53):8192-8195. (Pubitemid 35454423)